A Randomized, Double-Blind, Multiple-Dose, Parallel Group Study to Evaluate the Potential of Withdrawal Effects Following Administration of Oxycodone/Naltrexone Capsules and Oxycodone in Methadone-Maintained Opioid-Dependent Subjects

Trial Profile

A Randomized, Double-Blind, Multiple-Dose, Parallel Group Study to Evaluate the Potential of Withdrawal Effects Following Administration of Oxycodone/Naltrexone Capsules and Oxycodone in Methadone-Maintained Opioid-Dependent Subjects

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2015

At a glance

  • Drugs Oxycodone/naltrexone (Primary) ; Oxycodone
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Elite Pharmaceuticals
  • Most Recent Events

    • 23 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 23 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top